組織心臓弁の世界市場レポート 2025年

組織心臓弁の市場規模は、今後数年間で安定した成長が見込まれます。2029年には17億米ドルに成長し、CAGRは2.7%となります。予測期間の成長は、心血管疾患の有病率の上昇、無縫合手技の採用増加、高齢化人口の増加、心血管治療に対する需要の増加、ヘルスケア投資の増加に起因しています。この期間に予想される主な動向には、技術革新、高度培養システムの開発、画像技術の向上、手術手技の進歩、新興国におけるヘルスケア市場の拡大などがあります。

心血管疾患（CVD）の有病率の増加は、今後数年間の組織心臓弁市場の成長を牽引すると予想されます。心臓発作、脳卒中、高血圧などの疾患を含むCVDは、世界の死亡原因の上位を占めています。この増加の主な原因は、不健康なライフスタイル、高齢化、危険因子の有病率の増加、食生活の乱れ、運動不足、喫煙、ストレス、都市化であり、これらすべてが心臓関連疾患の発生率を高めています。組織心臓弁は、弁置換術を必要とする患者に生体適合性、耐久性、血栓形成性の低い解決策を提供し、最終的に長期的な心臓機能の改善と合併症の減少を実現することで、心血管疾患の治療に重要な役割を果たします。例えば、2024年9月、アメリカ心不全学会（HFSA）の報告書によると、20歳以上のアメリカ人のうち約670万人が心不全（HF）と共に生活しており、この数は2030年までに870万人、2040年までに1,030万人、2050年までに1,140万人に増加すると予測されています。このようにCVDの負担が増加していることが、組織心臓弁の需要に拍車をかけています。

組織心臓弁市場に参入している企業は、患者の予後を改善するための技術革新に注力しています。例えば、2024年6月、アイルランドを拠点とするテクノロジー企業Medtronic plcは、植え込み時の使いやすさを向上させ、患者の長期管理をサポートするように設計された次世代外科用大動脈組織弁であるAvalus Ultra弁を発売しました。10年にわたるアバラス弁の臨床経験を基に開発されたこの弁は、薄型、一貫した円形性を実現するポリエーテルエーテルケトン（PEEK）製ベースフレーム、血流を改善する業界トップクラスの有効開口面積（EOA）を特徴としています。さらに、将来的なバルブ・イン・バルブ手技における視認性を向上させ、大動脈弁狭窄症患者の長期的な耐久性を確保するために、放射線不透過性のコイルが含まれています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界組織心臓弁PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の組織心臓弁市場：成長率分析
• 世界の組織心臓弁市場の実績：規模と成長, 2019-2024
• 世界の組織心臓弁市場の予測：規模と成長, 2024-2029, 2034F
• 世界組織心臓弁総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の組織心臓弁市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ステント組織心臓弁
• ステントレス組織心臓弁
• 世界の組織心臓弁市場バルブタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 大動脈
• 僧帽弁
• 三尖弁
• 肺
• 世界の組織心臓弁市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 外来手術センター
• その他のエンドユーザー
• 世界の組織心臓弁市場ステント式組織心臓弁の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 牛心膜弁
• 豚弁
• 世界の組織心臓弁市場ステントレス組織心臓弁の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 牛心膜ステントレス弁
• 同種移植弁

第7章 地域別・国別分析

• 世界の組織心臓弁市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の組織心臓弁市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 組織心臓弁市場：競合情勢
• 組織心臓弁市場：企業プロファイル
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
  • LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Meril Life Sciences Pvt. Ltd.
• MicroPort Scientific Corporation
• LifeNet Health Inc.
• TTK Healthcare Ltd.
• Braile Biomedica
• On-X Life Technologies Inc.
• Anteris Technologies Ltd.
• Labcor Laboratorios Ltd.
• CARDION s.r.o.
• CryoLife Inc.
• Colibri Heart Valve LLC
• Foldax Inc.
• Balance Medical Technologies Co. Ltd.
• MiCardia Corporation
• Neovasc Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 組織心臓弁市場2029：新たな機会を提供する国
• 組織心臓弁市場2029：新たな機会を提供するセグメント
• 組織心臓弁市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Tissue heart valves are biological heart valves used in replacement surgeries, designed to function such as natural heart valves as an alternative to mechanical ones.

The primary types of tissue heart valves are stented and stentless valves. Stented tissue heart valves are bioprosthetic valves reinforced with a metal or polymer frame (stent) to provide structural support and simplify implantation during valve replacement procedures. These valves come in various types, including aortic, mitral, tricuspid, and pulmonary valves. They are utilized by multiple end-users, such as hospitals, ambulatory surgical centers, and other medical facilities.

The tissue heart valves market research report is one of a series of new reports from The Business Research Company that provides tissue heart valves market statistics, including the tissue heart valves industry global market size, regional shares, competitors with the tissue heart valves market share, detailed tissue heart valves market segments, market trends, and opportunities, and any further data you may need to thrive in the tissue heart valves industry. This tissue heart valves market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tissue heart valves market size has grown steadily in recent years. It will grow from $1.48 billion in 2024 to $1.53 billion in 2025 at a compound annual growth rate (CAGR) of 3.1%. The growth during the historic period can be attributed to the increasing prevalence of lifestyle diseases, rising healthcare expenditures, a growing elderly population, a surge in cardiac and pathological disorders, and the rising incidence of heart diseases.

The tissue heart valves market size is expected to see steady growth in the next few years. It will grow to $1.70 billion in 2029 at a compound annual growth rate (CAGR) of 2.7%. The projected growth in the forecast period can be attributed to the rising prevalence of cardiovascular diseases, the increasing adoption of sutureless procedures, a growing aging population, higher demand for cardiovascular treatments, and increased healthcare investments. Key trends expected during this period include technological innovations, the development of advanced culture systems, improvements in imaging technologies, advancements in surgical techniques, and the expansion of healthcare markets in emerging regions.

The increasing prevalence of cardiovascular diseases (CVDs) is expected to drive the growth of the tissue heart valves market in the coming years. CVDs, which include conditions such as heart attacks, strokes, and hypertension, are among the leading causes of mortality worldwide. This rise is primarily driven by unhealthy lifestyles, aging populations, increased prevalence of risk factors, poor diets, physical inactivity, smoking, stress, and urbanization, all contributing to higher rates of heart-related disorders. Tissue heart valves play a crucial role in treating cardiovascular diseases by offering a biocompatible, durable, and less thrombogenic solution for patients requiring valve replacement, ultimately improving long-term heart function and reducing complications. For example, in September 2024, a report by the Heart Failure Society of America (HFSA) stated that approximately 6.7 million Americans aged 20 and older are living with heart failure (HF), with projections estimating this number to rise to 8.7 million by 2030, 10.3 million by 2040, and 11.4 million by 2050. This rising burden of CVDs is fueling the demand for tissue heart valves.

Companies operating in the tissue heart valves market are focusing on technological innovations to improve patient outcomes. For instance, in June 2024, Medtronic plc, an Ireland-based technology company, launched the Avalus Ultra valve, a next-generation surgical aortic tissue valve designed to enhance ease of use during implantation and support long-term patient management. This valve, built on a decade of clinical experience with the Avalus valve, features a low profile, a polyetheretherketone (PEEK) base frame for consistent circularity, and an industry-leading Effective Orifice Area (EOA) to improve blood flow. Additionally, it includes a radiopaque coil for better visibility in future valve-in-valve procedures, ensuring long-term durability for patients with aortic stenosis.

In February 2024, Foldax Inc., a US-based medical device company, partnered with Dolphin Life Science India LLP to manufacture the Tria polymer mitral surgical heart valve in India. This collaboration enables in-country production and distribution, making advanced heart valve solutions more accessible to patients. Dolphin Life Science India LLP is an India-based life sciences company specializing in heart valve manufacturing and distribution.

Major players in the tissue heart valves market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, LifeNet Health Inc., TTK Healthcare Ltd., Braile Biomedica, On-X Life Technologies Inc., Anteris Technologies Ltd., Labcor Laboratorios Ltd., CARDION s.r.o., CryoLife Inc., Colibri Heart Valve LLC, Foldax Inc., Balance Medical Technologies Co. Ltd., MiCardia Corporation, Neovasc Inc.

North America was the largest region in the tissue heart valves market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tissue heart valves report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tissue heart valves market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tissue heart valves market consists of sales of porcine xenograft valves, bovine pericardial valves, and autograft valves. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tissue Heart Valves Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tissue heart valves market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue heart valves ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tissue heart valves market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Stented Tissue Heart Valves; Stentless Tissue Heart Valves
• 2) By Valve Type: Aortic; Mitral; Tricuspid; Pulmonary
• 3) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
• Subsegments:
• 1) By Stented Tissue Heart Valves: Bovine Pericardial Valves; Porcine Valves
• 2) By Stentless Tissue Heart Valves: Bovine Pericardial Stentless Valves; Homograft Valves
• Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; Edwards Lifesciences Corporation; LivaNova PLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tissue Heart Valves Market Characteristics

3. Tissue Heart Valves Market Trends And Strategies

4. Tissue Heart Valves Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Tissue Heart Valves Growth Analysis And Strategic Analysis Framework

• 5.1. Global Tissue Heart Valves PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Tissue Heart Valves Market Growth Rate Analysis
• 5.4. Global Tissue Heart Valves Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Tissue Heart Valves Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Tissue Heart Valves Total Addressable Market (TAM)

6. Tissue Heart Valves Market Segmentation

• 6.1. Global Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stented Tissue Heart Valves
• Stentless Tissue Heart Valves
• 6.2. Global Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Aortic
• Mitral
• Tricuspid
• Pulmonary
• 6.3. Global Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Other End-Users
• 6.4. Global Tissue Heart Valves Market, Sub-Segmentation Of Stented Tissue Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bovine Pericardial Valves
• Porcine Valves
• 6.5. Global Tissue Heart Valves Market, Sub-Segmentation Of Stentless Tissue Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bovine Pericardial Stentless Valves
• Homograft Valves

7. Tissue Heart Valves Market Regional And Country Analysis

• 7.1. Global Tissue Heart Valves Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Tissue Heart Valves Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tissue Heart Valves Market

• 8.1. Asia-Pacific Tissue Heart Valves Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tissue Heart Valves Market

• 9.1. China Tissue Heart Valves Market Overview
• 9.2. China Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tissue Heart Valves Market

• 10.1. India Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tissue Heart Valves Market

• 11.1. Japan Tissue Heart Valves Market Overview
• 11.2. Japan Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tissue Heart Valves Market

• 12.1. Australia Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tissue Heart Valves Market

• 13.1. Indonesia Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tissue Heart Valves Market

• 14.1. South Korea Tissue Heart Valves Market Overview
• 14.2. South Korea Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tissue Heart Valves Market

• 15.1. Western Europe Tissue Heart Valves Market Overview
• 15.2. Western Europe Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tissue Heart Valves Market

• 16.1. UK Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tissue Heart Valves Market

• 17.1. Germany Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tissue Heart Valves Market

• 18.1. France Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tissue Heart Valves Market

• 19.1. Italy Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tissue Heart Valves Market

• 20.1. Spain Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tissue Heart Valves Market

• 21.1. Eastern Europe Tissue Heart Valves Market Overview
• 21.2. Eastern Europe Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tissue Heart Valves Market

• 22.1. Russia Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tissue Heart Valves Market

• 23.1. North America Tissue Heart Valves Market Overview
• 23.2. North America Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tissue Heart Valves Market

• 24.1. USA Tissue Heart Valves Market Overview
• 24.2. USA Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tissue Heart Valves Market

• 25.1. Canada Tissue Heart Valves Market Overview
• 25.2. Canada Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tissue Heart Valves Market

• 26.1. South America Tissue Heart Valves Market Overview
• 26.2. South America Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tissue Heart Valves Market

• 27.1. Brazil Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tissue Heart Valves Market

• 28.1. Middle East Tissue Heart Valves Market Overview
• 28.2. Middle East Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tissue Heart Valves Market

• 29.1. Africa Tissue Heart Valves Market Overview
• 29.2. Africa Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tissue Heart Valves Market Competitive Landscape And Company Profiles

• 30.1. Tissue Heart Valves Market Competitive Landscape
• 30.2. Tissue Heart Valves Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis

31. Tissue Heart Valves Market Other Major And Innovative Companies

• 31.1. Meril Life Sciences Pvt. Ltd.
• 31.2. MicroPort Scientific Corporation
• 31.3. LifeNet Health Inc.
• 31.4. TTK Healthcare Ltd.
• 31.5. Braile Biomedica
• 31.6. On-X Life Technologies Inc.
• 31.7. Anteris Technologies Ltd.
• 31.8. Labcor Laboratorios Ltd.
• 31.9. CARDION s.r.o.
• 31.10. CryoLife Inc.
• 31.11. Colibri Heart Valve LLC
• 31.12. Foldax Inc.
• 31.13. Balance Medical Technologies Co. Ltd.
• 31.14. MiCardia Corporation
• 31.15. Neovasc Inc.

32. Global Tissue Heart Valves Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tissue Heart Valves Market

34. Recent Developments In The Tissue Heart Valves Market

35. Tissue Heart Valves Market High Potential Countries, Segments and Strategies

• 35.1 Tissue Heart Valves Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Tissue Heart Valves Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Tissue Heart Valves Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer